Research
Hormonal
Pharmacological weight loss therapy is indicated for BMI ≥ 30 kg/m² or BMI ≥ 27 kg/m² with comorbidities, aiming for ≥ 5% weight loss within 3-4 months of reaching the target dose.
If lifestyle changes alone aren't enough and your BMI is high (≥30 or ≥27 with health issues), ask your doctor about approved weight-loss medications. These are used alongside lifestyle changes and aim for at least 5% weight loss within a few months of reaching the full dose.
StrongSupportsHIGH confidence
Pharmakologische Therapien haben zum Ziel, innerhalb von 3 bis 4 Monaten nach Erreichen der Zieldosis bzw. der höchsten verträglichen Dosierung eine Reduktion des Körpergewichts um zumindest 5 % zu erreichen.
Why this rating
Consensus guideline recommendation.
Source
Übergewicht und Adipositas bei Erwachsenen: allgemeine Behandlungsgrundsätze und konservatives Management
Johanna Brix et al. · Wiener klinische Wochenschrift · 2023
DOI 10.1007/s00508-023-02270-9
clinical_guidelineCited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Conservative management of obesity requires a structured, multidisciplinary lifestyle intervention (energy-reduced diet, increased physical activity, behavioral therapy) targeting a 5-10% weight loss within 6 months to improve comorbidities.Strong
- Obesity is a complex chronic disease requiring multidisciplinary care, and stigma contributes to morbidity and mortality.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →